Fujiwara Keiichi, Yokosuka Osamu, Imazeki Fumio, Miki Makoto, Suzuki Kazuyuki, Okita Kiwamu, Tanaka Eiji, Omata Masao
Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
J Gastroenterol. 2007 Jul;42(7):560-6. doi: 10.1007/s00535-007-2039-7. Epub 2007 Jul 25.
In our recent study of the full-length hepatitis A virus (HAV) genome from some patients with fulminant hepatitis and acute hepatitis, possible associations were suggested between the severity of hepatitis A and the amino acid substitutions in the nonstructural protein 2B. We therefore analyzed HAV 2B from many patients with various clinical disease severities.
Serum samples from 30 Japanese patients with sporadic hepatitis A from five widely separated regions of Japan, comprising nine patients with fulminant hepatitis (FH), six with severe acute hepatitis (AHs), and 15 with acute hepatitis (AH), were examined for HAV RNA. The entire sequences of HAV 2B were analyzed.
Compared with the sequence of the wild-type HAV strain GBM, nucleotide sequences of 2B had homology of 94.5 +/- 1.0% in FH, 95.2 +/- 1.2% in AHs, and 95.1 +/- 1.8% in AH. Deduced amino acid sequences had homology of 97.5 +/- 2.1% in FH, 97.9 +/- 2.4% in AHs, and 98.5 +/- 1.3% in AH. Differences were not statistically significant among the three groups. The average number of amino acid mutations between amino acids 100 and 200 was 5.0 +/- 5.2 per case in FH, 4.0 +/- 6.0 in AHs, and 1.9 +/- 2.9 in AH. The differences between FH and AH, AHs and AH, and between severe cases (FH and AHs) and nonsevere cases (AH) were not statistically significant (P = 0.13, P = 0.45, and P = 0.10, respectively).
There were no obvious differences in the sequences among FH, AHs, and AH throughout the 2B region, but there seemed to be more mutations in the strains obtained from FH and AHs patients than in those obtained from AH patients in the central part of HAV 2B.
在我们最近对一些暴发性肝炎和急性肝炎患者的甲型肝炎病毒(HAV)全长基因组的研究中,提示甲型肝炎的严重程度与非结构蛋白2B中的氨基酸替换之间可能存在关联。因此,我们分析了许多不同临床疾病严重程度患者的HAV 2B。
检测了来自日本五个广泛分布地区的30例散发性甲型肝炎日本患者的血清样本中的HAV RNA,这些患者包括9例暴发性肝炎(FH)患者、6例严重急性肝炎(AHs)患者和15例急性肝炎(AH)患者。分析了HAV 2B的完整序列。
与野生型HAV毒株GBM的序列相比,2B的核苷酸序列在FH患者中同源性为94.5±1.0%,在AHs患者中为95.2±1.2%,在AH患者中为95.1±1.8%。推导的氨基酸序列在FH患者中同源性为97.5±2.1%,在AHs患者中为97.9±2.4%,在AH患者中为98.5±1.3%。三组之间的差异无统计学意义。在FH患者中,每个病例100至200位氨基酸之间的平均氨基酸突变数为5.0±5.2,在AHs患者中为4.0±6.0,在AH患者中为1.9±2.9。FH与AH、AHs与AH以及重症病例(FH和AHs)与非重症病例(AH)之间的差异无统计学意义(P分别为0.13、0.45和0.10)。
在整个2B区域,FH、AHs和AH的序列没有明显差异,但在HAV 2B中部,从FH和AHs患者分离出的毒株似乎比从AH患者分离出的毒株有更多突变。